Frequently Asked Questions

You can apply online at: http:/gradstudies.case.edu/prospect/admissions/apply.html

Once your application is complete, your information will be forwarded to the Admissions Committee of the Department of Molecular Medicine. An interview and tour will be scheduled for competitive applicants.

For Fall 2018 enrollment, applications are due on January 1st. Apply by December 8th to be considered for Early Review.

The application fee for the Molecular Medicine Ph.D. Program is $50.

Fee waivers can be requested by contacting the Molecular Medicine Ph.D. Program directly at molmedphd@ccf.org. Please be prepared to explain the need based circumstances of your request.

For Early Decision,  applicants will be notified via email after December 18th. For general applications (due by January 1st), review will begin immediately following the deadline and decisions will be sent out in the weeks following. The Admissions Committee will do its best to notify all applicants in a timely fashion.

Please submit official GRE and TOEFL scores to institutional code 1105.

Applications: If your disability impairs your ability to use the online application, please contact Sarah Kostiha Smith (kostihs@ccf.org).
Interview: If your disability prevents you from attending the on-site interview, please contact Sarah Kostiha Smith for alternative arrangements (Skype, phone, or faculty visit).
Accommodations during graduate school: Cleveland Clinic and CWRU will make every effort to accommodate your specific needs through our Disability Task Force and Disabilities Resource Office.

The Molecular Medicine Ph.D. Program is part of the Cleveland Clinic Lerner College of Medicine (CCLCM) of Case Western Reserve University. Students will have opportunities to take part in research at both the Lerner Research Institute within the Cleveland Clinic and Case Western Reserve University. The Lerner Research Institute is home to laboratory-based and translational research at the Cleveland Clinic. Their are more than 150 Faculty investigators in the Lerner Research Institute who have appointments in the Molecular Medicine Ph.D. Program. Research at the Institute focuses on disease oriented programs, including cancer, cardiovascular, neurologic, musculoskeletal, eye, allergic and immunologic, metabolic, and infectious diseases.

Core curriculum courses are taught on the Cleveland Clinic campus, with advanced electives available on both the Cleveland Clinic and Case Western Reserve University campuses.

Your Thesis Committee will be appointed by the end of the second summer with consultation between you, your Thesis Advisor and the Program Director. Your Thesis Committee will be comprised of your Thesis Advisor, Clinical Mentor, and two other Case Western Reserve University Faculty members. The members of your committee will meet with you two times per year to provide feedback on your research project and guide you through the program in a timely manner.

All students accepted into the Molecular Medicine Ph.D. Program will receive a stipend and free tuition throughout their graduate training. Stipend amounts are set by Case Western Reserve University. Health insurance will be provided through Case Western Reserve University.

Molecular Medicine Ph.D. students can participate in the student programs at both Case Western Reserve University and the Cleveland Clinic's Lerner Research Institute. The Lerner Research Institute's Graduate Student Association plans and provides academic and social functions for all graduate students working in labs at the Cleveland Clinic. New graduate students are encouraged to join this group to facilitate both social and professional networking in the Institute's research community.

Upon successful completion of all coursework, research requirements, and thesis (including defense of your research project), you will graduate with a Ph.D. in Molecular Medicine from Case Western Reserve University.